Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

SHA:600529 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	954.9	1,065	1,466	1,352	885.04	1,132
Trading Asset Securities	1,692	1,725	1,218	1,101	307.13	230.5
Cash & Short-Term Investments	2,647	2,790	2,684	2,453	1,192	1,362
Cash Growth	-11.79%	3.95%	9.40%	105.80%	-12.49%	-10.47%
Accounts Receivable	1,604	1,732	1,701	1,551	1,200	943.19
Other Receivables	2.18	1.87	1.78	2.24	3.38	5.39
Receivables	1,606	1,734	1,703	1,553	1,203	948.58
Inventory	1,541	1,279	1,055	1,210	877.74	749.2
Prepaid Expenses	1.97	-	-	-	-	1.48
Other Current Assets	109.6	177.99	103.8	104.63	61.99	82.5
Total Current Assets	5,907	5,980	5,546	5,321	3,335	3,144
Property, Plant & Equipment	3,706	3,786	3,465	2,821	2,557	2,113
Long-Term Investments	0.05	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	244.35	247.24	253.67	260.37	198.37	203.25
Long-Term Deferred Tax Assets	89.77	74.46	37.8	32.01	32.42	29.63
Other Long-Term Assets	28.67	51.73	16.79	349.91	287.01	131.71
Total Assets	9,975	10,140	9,319	8,784	6,410	5,621
Accounts Payable	1,241	1,583	1,394	1,418	1,436	995.78
Accrued Expenses	252.21	209.47	149.8	130.47	126.18	153.21
Short-Term Debt	-	-	1.83	5.2	-	-
Current Income Taxes Payable	13.62	30.25	16.65	14.87	15.25	43.53
Current Unearned Revenue	61.32	60	61.79	51.04	74.61	64.68
Other Current Liabilities	112.38	118.07	102.83	144.13	27.74	48.33
Total Current Liabilities	1,681	2,001	1,727	1,764	1,679	1,306
Long-Term Unearned Revenue	129.99	131.67	57.62	58.95	59.97	60
Total Liabilities	1,811	2,132	1,784	1,823	1,739	1,366
Common Stock	663.61	663.61	663.61	663.61	594.97	594.97
Additional Paid-In Capital	2,687	2,687	2,687	2,687	913.45	913.45
Retained Earnings	4,749	4,591	4,112	3,535	3,096	2,683
Comprehensive Income & Other	64.38	66.39	71.59	75.48	66.22	64.4
Total Common Equity	8,165	8,008	7,535	6,962	4,670	4,256
Shareholders' Equity	8,165	8,008	7,535	6,962	4,670	4,256
Total Liabilities & Equity	9,975	10,140	9,319	8,784	6,410	5,621
Total Debt	-	-	1.83	5.2	-	-
Net Cash (Debt)	2,647	2,790	2,682	2,448	1,192	1,362
Net Cash Growth	-11.79%	4.02%	9.56%	105.36%	-12.49%	-10.47%
Net Cash Per Share	3.99	4.20	4.05	4.08	2.00	2.29
Filing Date Shares Outstanding	663.61	663.61	663.61	663.61	594.97	594.97
Total Common Shares Outstanding	663.61	663.61	663.61	663.61	594.97	594.97
Working Capital	4,226	3,980	3,819	3,557	1,656	1,839
Book Value Per Share	12.30	12.07	11.35	10.49	7.85	7.15
Tangible Book Value	7,920	7,761	7,281	6,701	4,472	4,053
Tangible Book Value Per Share	11.93	11.69	10.97	10.10	7.52	6.81
Buildings	2,157	2,149	1,911	1,507	1,402	1,184
Machinery	3,482	3,426	2,745	983.08	2,004	1,673
Construction In Progress	230.32	215.36	470.14	475.18	342.58	314.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.